Tvardi Therapeutics, Inc. (TVRD) — S-1/A Filings
All S-1/A filings from Tvardi Therapeutics, Inc.. Browse 2 S-1/A reports with AI-powered summaries and risk analysis.
S-1/A Filings (2)
-
Tvardi Faces Going Concern Doubt After Merger, IPF Trial Misses Goals
— Oct 20, 2025 Risk: high
Tvardi Therapeutics, Inc. (TVRD) completed a merger with Legacy Tvardi on April 15, 2025, following a 1-for-3 reverse stock split and an increase in authorized -
Tvardi Therapeutics Files S-1/A for Resale, Eyes Key Clinical Readouts
— Oct 7, 2025 Risk: high
Tvardi Therapeutics, Inc. (TVRD) filed an S-1/A on October 7, 2025, detailing its post-merger operations and a resale offering of 2,084,117 shares of common sto
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX